| No images? Click here  Wednesday 10 February WHO Strategic Advisory Group of Experts on Immunization (SAGE) Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca OverviewThis interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its extraordinary meeting on 8 February 2021. Link: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1/ RELATED AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paperOverviewThis document provides the background evidence related to the Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca
 Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
Wednesday, February 10, 2021
WHO SAGE: Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment